PSMA-PET/CT AND WHOLE-BODY MRI FOR STAGING AND RESTAGING OF PROSTATE CANCER PATIENTS

被引：0
|
作者：
Greco, Elena [1 ]
Bianchi, Lorenzo [2 ]
Gaudiano, Cristina [3 ]
Corcioni, Beniamino [3 ]
Spinozzi, Luca
Catanzaro, Calogero [4 ]
Mignogna, Chiara [4 ]
Renzetti, Benedetta [5 ]
Cattabriga, Arrigo [3 ]
Schiavina, Riccardo [2 ]
Brunocilla, Eugenio [2 ]
Mosconi, Cristina [3 ]
Castellucci, Paolo [6 ]
Fanti, Stefano [6 ]
Farolfi, Andrea [6 ]
机构：
[1] Alma Mater Studiorum Univ Bologna, Nucl Med, Bologna, Italy
[2] IRCCS Azienda Osped Univ Bologna, Div Urol, Bologna, Italy
[3] Irccs Azienda Osped Univ Bologna, Dept Radiol, Bologna, Italy
[4] Alma Mater Studiorum Univ Bologna, Div Urol, Bologna, Italy
[5] Alma Mater Studiorum Univ Bologna, Dept Radiol, Bologna, Italy
[6] IRCCS Azienda Osped Univ Bologna, Nucl Med, Bologna, Italy
来源：
ANTICANCER RESEARCH | 2024年 / 44卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
57
引用
收藏
页数：45
相关论文
共 50 条
  • [31] Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT
    Karagiannis, Vasileios
    Wichmann, Viktor
    Saarinen, Juha
    Eigeliene, Natalja
    Andersen, Heidi
    Jekunen, Antti
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [32] Whole-Body PET/MRI for Colorectal Cancer Staging: Is It the Way Forward?
    Lee, Dong Ho
    Lee, Jeong Min
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2017, 45 (01) : 21 - 35
  • [33] The phytological future of prostate cancer staging: PSMA-PET and the dandelion theory
    Sathianathen, Niranjan J.
    Geurts, Nicolas
    Nair, Rajesh
    Lawrentschuk, Nathan
    Murphy, Declan G.
    Lamb, Alastair D.
    FUTURE ONCOLOGY, 2017, 13 (20) : 1801 - 1807
  • [34] Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT
    Vasileios Karagiannis
    Viktor Wichmann
    Juha Saarinen
    Natalja Eigeliene
    Heidi Andersen
    Antti Jekunen
    Radiation Oncology, 17
  • [35] 68Ga-PSMA PET/CT whole-body tumor burden in patients with biochemical recurrence of prostate cancer
    Biggi Mattiolli, A.
    Lima, M. C. L.
    Camacho, M.
    Ramos, C. D.
    Santos, A. O.
    Etchebehere, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S307 - S307
  • [36] PSMA-PET/CT imaging in prostate cancer: why and when
    Ceci, Francesco
    Fanti, Stefano
    CLINICAL AND TRANSLATIONAL IMAGING, 2019, 7 (06) : 377 - 379
  • [37] Cost considerations for whole-body MRI and PET/CT as part of oncologic staging
    Plathow, C.
    Walz, M.
    Lichy, M. P.
    Aschoff, P.
    Pfannenberg, C.
    Bock, H.
    Eschmann, S. M.
    Claussen, C. D.
    Schlemmer, H. P.
    RADIOLOGE, 2008, 48 (04): : 384 - 396
  • [38] PSMA-PET/CT imaging in prostate cancer: why and when
    Francesco Ceci
    Stefano Fanti
    Clinical and Translational Imaging, 2019, 7 : 377 - 379
  • [39] Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer
    Andrew Barakat
    Basel Yacoub
    Maria El Homsi
    Amro Saad Aldine
    Albert El Hajj
    Mohamad B. Haidar
    Scientific Reports, 10
  • [40] SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer
    Schmidkonz, Christian
    Cordes, Michael
    Beck, Michael
    Goetz, Theresa Ida
    Schmidt, Daniela
    Prante, Olaf
    Baeuerle, Tobias
    Uder, Michael
    Wullich, Bernd
    Goebell, Peter
    Kuwert, Torsten
    Ritt, Philipp
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 225 - 231
12345